Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of NaxSwab vs Naloxone Spray and IM in Healthy Volunteers
NCT05363501Phase 1Completed
- Sponsor
- Pocket Naloxone Corp.
- Start
- Jan 2021
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of naloxone in opioid overdose (10 arms), sponsored by Pocket Naloxone Corp. Primary endpoints: Maximum Plasma Concentration at 13 days, Area Under the Curve at 13 days and 1 more. Started Jan 2021; status: completed.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT05363501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05363501.